findmyKOL
Clinical trialNCT05986851Active, not recruitingPhase 2Interventional

Azeliragon in MGMT Unmethylated Glioblastoma

SponsorCantex PharmaceuticalsEnrollment30Glioblastoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, United States

  • Miami Cancer Institute - Baptist Health

    Miami, Florida, United States

  • Corewell Health

    Royal Oak, Michigan, United States

  • Washington University in St. Louis

    St Louis, Missouri, United States

  • Lenox Hill Hospital

    New York, New York, United States

  • the University of Oklahoma Health Science Center

    Oklahoma City, Oklahoma, United States

  • University of Utah Health Huntsman Cancer Center

    Salt Lake City, Utah, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Sept 2023
Primary completion
30 Sept 2026
Completion
30 Dec 2026
Last update posted
31 Mar 2026
Registered enrollment
30
Registry id
NCT05986851

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.